PERSPECTIVE THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Basic Shares Outstanding (Weighted Average) of 120.65 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- PERSPECTIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 120.65M shares, a 62.53% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 103.60M shares, a 43.18% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 74.34M shares, a 4.97% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 74.30M shares, a 5.19% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 73.81M shares, a 14.57% increase from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 64.42M shares, a 140.72% increase from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 26.76M shares, a 81.16% decline from fiscal 2022.
- PERSPECTIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 142.07M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 120.65M shares 10-Q · filed 2026-08-10 | 112.17M shares 10-Q · filed 2026-08-10 | 99.53M shares derived: average of 3 quarters · filed 2026-08-10 | 93.22M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | 103.60M shares 10-Q · filed 2026-05-11 | 88.97M shares derived: average of 2 quarters · filed 2026-05-11 | 84.08M shares derived: average of 3 quarters · filed 2026-05-11 | 81.62M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | 74.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 74.32M shares derived: average of 2 quarters · filed 2026-03-16 | 74.29M shares derived: average of 3 quarters · filed 2026-08-10 | 73.81M shares 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | 74.30M shares 10-Q · filed 2025-11-10 | 74.27M shares derived: average of 2 quarters · filed 2026-08-10 | 73.64M shares 10-Q · filed 2025-11-10 | 72.93M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | 74.23M shares 10-Q · filed 2026-08-10 | 73.30M shares 10-Q · filed 2026-08-10 | 72.47M shares derived: average of 3 quarters · filed 2026-08-10 | 72.01M shares derived: average of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | 72.36M shares 10-Q · filed 2026-05-11 | 71.59M shares derived: average of 2 quarters · filed 2026-05-11 | 71.27M shares derived: average of 3 quarters · filed 2026-05-11 | 70.11M shares derived: average of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | 70.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 70.72M shares derived: average of 2 quarters · filed 2026-03-16 | 69.37M shares derived: average of 3 quarters · filed 2026-03-16 | 64.42M shares 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | 70.63M shares 10-Q · filed 2025-11-10 | 68.64M shares derived: average of 2 quarters · filed 2025-11-10 | 62.29M shares 10-Q · filed 2025-11-10 | 53.72M shares derived: average of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | 66.65M shares 10-Q · filed 2025-08-13 | 58.08M shares 10-Q · filed 2025-08-13 | 48.08M shares derived: average of 3 quarters · filed 2025-08-13 | 43.08M shares derived: average of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | 49.51M shares 10-Q · filed 2025-05-12 | 495.10M shares 10-Q · filed 2024-05-15 | 38.80M shares derived: average of 2 quarters · filed 2025-05-12 | 35.22M shares derived: average of 3 quarters · filed 2025-05-12 | 33.41M shares derived: average of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | 28.09M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-03-28 | 28.07M shares derived: average of 2 quarters · filed 2025-03-28 | 28.05M shares derived: average of 3 quarters · filed 2025-03-28 | 26.76M shares 10-K/A · filed 2025-03-28 | 267.64M shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 28.05M shares 10-Q · filed 2024-11-12 | 280.56M shares 10-Q · filed 2023-11-14 | 28.03M shares derived: average of 2 quarters · filed 2024-11-12 | 26.32M shares 10-Q · filed 2024-11-12 | 263.24M shares 10-Q · filed 2023-11-14 | 106.69M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 28.00M shares 10-Q · filed 2024-08-13 | 279.99M shares 10-Q · filed 2023-08-11 | 25.44M shares 10-Q · filed 2024-08-13 | 254.43M shares 10-Q · filed 2023-08-11 | 132.91M shares derived: average of 3 quarters · filed 2024-08-13 | 135.20M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 228.59M shares 10-Q · filed 2024-05-15 | 185.36M shares derived: average of 2 quarters · filed 2024-05-15 | 170.93M shares derived: average of 3 quarters · filed 2024-05-15 | 163.71M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 142.13M shares derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28 | 142.10M shares 10-K · filed 2024-03-28 | 142.08M shares derived: average of 3 quarters · filed 2024-03-28 | 142.07M shares 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | 142.07M shares 10-Q · filed 2023-11-14 | 142.06M shares derived: average of 2 quarters · filed 2023-11-14 | 142.05M shares 10-Q · filed 2023-11-14 | 142.03M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 142.04M shares 10-Q · filed 2023-08-11 | 142.04M shares 10-Q · filed 2023-08-11 | 142.01M shares derived: average of 3 quarters · filed 2023-08-11 | 141.99M shares 10-K · filed 2024-03-28 | ||||
| 2022-03-31 | 142.04M shares 10-Q · filed 2023-05-15 | 142.00M shares derived: average of 2 quarters · filed 2023-05-15 | 141.97M shares 10-Q · filed 2022-05-13 | 141.90M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 141.96M shares 10-K · filed 2022-09-28 | 141.94M shares 10-KT · filed 2023-05-01 | 141.85M shares derived: average of 3 quarters · filed 2022-11-14 | 137.03M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-09-30 | 141.91M shares 10-Q · filed 2022-11-14 | 141.79M shares derived: average of 2 quarters · filed 2022-11-14 | 135.38M shares derived: average of 3 quarters · filed 2022-11-14 | 122.30M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 141.67M shares 10-K · filed 2022-09-28 | 132.12M shares derived: average of 2 quarters · filed 2022-09-28 | 115.76M shares derived: average of 3 quarters · filed 2022-09-28 | 103.84M shares 10-KT · filed 2023-05-01 | ||||
| 2021-03-31 | 122.57M shares 10-K · filed 2022-09-28 | 102.81M shares derived: average of 2 quarters · filed 2022-09-28 | 91.28M shares 10-Q · filed 2022-05-13 | |||||
| 2020-12-31 | 83.05M shares 10-K · filed 2022-09-28 | 75.97M shares derived: average of 2 quarters · filed 2022-09-28 | ||||||
| 2020-09-30 | 68.90M shares 10-K · filed 2022-09-28 | |||||||
| 2020-06-30 | 67.60M shares 10-KT · filed 2023-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |